MarketPeel
Insider Trading Intelligence
JB

John P. Brancaccio

CRDF
DIRECTOR · CARDIFF ONCOLOGY, INC. · CIK 0001276551
FILING MIX · LIFETIME100%/0%
BUYS
16
SELLS
0
TOTAL VALUE
$87.3K
COMPANIES
2
ACTIVE SINCE
May 2020
HOLDINGS NOW
160,518
AVG SELL PX
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by John P. Brancaccio, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+33.33%+10.37%+0.46%+9.92%+2.72%
14d3+33.33%+20.60%+2.08%+18.52%-3.45%
30d3+33.33%+11.88%+3.69%+8.19%-14.93%
60d3+33.33%+58.28%+5.95%+52.33%-15.78%
90d3+33.33%+81.39%+10.98%+70.41%-21.54%
180d3+33.33%+350.00%+18.43%+331.56%-43.98%
1y3+33.33%+124.58%+30.88%+93.70%-76.32%
2y3+33.33%-28.80%+33.36%-62.16%-51.41%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRDF · 125,317 shares · as of Jun 9, 2022
031,32962,65993,988125,31720212022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 16 buys / 0 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OKYO
OKYO PHARMA LTD
PURCHASEGRANT
Stock grant
5,000$1.48$7.4K35,201Jul 21, 2026Jul 23, 2026View →
OKYO
OKYO PHARMA LTD
PURCHASEGRANT
Stock grant
6,500$1.85$12.0K138,394Jun 8, 2026Jun 10, 2026View →
OKYO
OKYO PHARMA LTD
PURCHASE
16,670$1.50$25.0K16,670Sep 15, 2023Sep 28, 2023View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
755125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
195125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
28,858125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
26,800125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
530125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
22,000125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
223125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
44,734125,317Jun 9, 2022Jun 9, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
26,800125,317Mar 9, 2022Mar 10, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
22,00098,517Jun 10, 2021Jun 14, 2021View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
3,000$10.95$32.9K12,260Mar 22, 2021Mar 22, 2021View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
28,85876,517Jun 17, 2020Jun 19, 2020View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
6,993$1.43$10.0K9,260May 14, 2020May 18, 2020View →
Other insiders · CRDF
Loading peer insiders…
About this filer
CIK 0001276551
ROLE
Director
PRIMARY
CRDF
COMPANIES
2
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001276551DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback